Skip to main content

Table 2 Response of study participants to chloroquine drug during 28 days follow-up in Halaba Kulite Health Center, South Ethiopia, January 2009.

From: Therapeutic efficacy of chloroquine for treatment of Plasmodium vivax malaria cases in Halaba district, South Ethiopia

Follow-up

period

At Risk

Excluded

from the

study for

different

reasons

Treatment

failure

Survival

Probability

Estimate

0.95 Confidence

Interval

     

Lower

Limit

Upper

Limit

Day 0

87

0

0

1

0.9473

1

Day 1

87

4

0

1

0.9473

1

Day 2

84

0

0

1

0.9473

1

Day 3

83

2

0

1

0.9473

1

Day 7

81

0

4

0.9506

0.8755

0.9833

Day 14

72

0

6

0.8714

0.7784

0.9305

Day 21

60

1

1

0.8569

0.7617

0.9197

Day 28

58

0

0

0.8569

0.7616

0.9197